Executive Council

Mr. Dennis Urbaniak, Chairman - email

Areas of expertise: Change management, innovation process, executive leadership, customer centric
marketing and sales, performance management.

  • Vice President, U.S. Diabetes, Sanofi
  • Vice President, Innovation and New Customer Channels, Sanofi-Aventis (former)
  • Vice President, Lovenox Marketing, Sanofi-Aventis (former)
  • Director, Plavix Marketing, Sanofi-Aventis (former)

Dr. Laurent Audoly, Member

Areas of expertise: People leadership and drug development experience across the R&D spectrum of activities with both small and large molecules; drug candidate identification, nomination, and development across multiple disease areas; basic research to the clinic with LOS to the market; global collaborations with academia and industry.

  • Head of R&D - Chief Scientific Officer, Pieris AG
  • Discovery Biologics Site Lead, Merck (former)
  • Senior Director Merck BioVentures, Merck (former)
  • Senior Director Biologics Research, Merck (former)

Mr. Lewis Feldberg, Member

Experience in Mergers and Acquisitions, Strategy, Licensing, Business Development, Establishment of New Affiliates

  • Chief Executive Officer, Esteve USA Inc.
  • Vice President-Business Development, Strategy, Country Cluster, Teva Europe – Netherlands
  • Senior Director & Assistant to CEO, Teva Pharmaceutical Industries –Israel
  • Columbia University Business School, MBA ; University of Chicago, BA

Dr. Albert Jaramillo, Member - email

Global HR Strategy & Transformation, Global Diversity & Inclusion Issues, Organization Development, Change Management, Talent Management, Six Sigma (Black Belt), and Project Management.

  • Vice President, Human Resources, Global R&D, Pfizer
  • Director, Talent Management Systems, Cardinal Health (former)
  • Vice President. Leadership Development, JPMorgan Chase (former)
  • PhD University of Michigan, BA Stanford

Dr. Shirish Kulkarni, Member - email

NDDS, Preformulation, Formulation Development, Tech Transfer, CMC, IND, NDA, ANDA, 505(b)(2) NDA, Clinical studies, BA-BE studies. Extensive international experience in drug development & regulatory (CMC) submissions to bring new drugs and dosage forms to market to alleviate human suffering.

  • Vice President, Pharma R&D (Innovations), Lupin Laboratories
  • Associate Director at GPC Biotech Inc. Princeton
  • Formulation Scientist, Monsanto
  • Drugs Inspector at FDA, Govt. of Maharashtra

Mr. David Motherway, Member

Areas of expertise: Business development, sales leadership, product development.

  • Account Executive, Department of Veterans Affairs, GE Healthcare
  • Senior Director, Government Initiatives, GE Healthcare (former) 
  • Director, Strategic Initiatives, GE Healthcare (former)
  • Director, Technology Sales, GE Healthcare (former)

Mr. Michael Naimoli, Member - email

Project management, data management issues and solutions, FDA regulatory compliance, experienced in the drug discovery and development process, issues pertaining to the technology transfer of products and methodologies through the product lifecycle.

  • Worldwide Managing Director, Life Sciences, Microsoft
  • Partner and Alliance Manager, Microsoft (former)
  • Consultant, Motorola (former)
  • Senior Biochemistry Specialist, Glaxo SmithKline (former)
  • University of Pennsylvania, MBA/MSE ; Penn State University, BS in Molecular Biology

Mr. Richard Smith, Member

Deep understanding of the valuable role logistics serve in connecting people and goods and creating economic growth; customized logistics and supporting specialized services; supply chain strategy; global life science products and medical device shipping and transportation.

  • Managing Director, Life Sciences & Specialty Services, FedEx Express
  • Manager of Supply Chain Solutions, FedEx Express Services (former)
  • Board Member, Greater Memphis Chamber of Commerce; Member of Aerotropolis Steering Committee 
  • Board Member, LeBonheur Children’s Hospital Foundation
  • University of Mississippi School of Law, JD; George Washington University, BS

Dr. Eckhard von Keutz, Member - email

Areas of expertise: Supervising large departments/institutes, managing inter-disciplinary teams, leading re-structuring and continuous improvement processes, regulatory expertise, designing and conducting preclinical/toxicological studies, toxicological risk assessment/management.

  • Senior Vice President, Head Global Early Development, Bayer HealthCare
  • Vice President, Global Head HealthCare Toxicology, Bayer AG (former)
  • Senior Director, Global Head of Toxicology-Pharma, Bayer AG (former)
  • Scientific coordinator in Toxicology Institute, Bayer AG (former)